Efficacy Results of a SURPASS open-label, phase III trial, published in 2021, demonstrated tirzepatides superior glycaemic efficacy and weight reduction compared with existing GLP-1 receptor agonists, including semaglutide 6
Consult your prescriber before adjusting increasing dose without addressing those variables wastes the injection
If you do, your blood sugar levels may increase and put you at risk of serious complications
Mechanistic study with primary hepatocytes revealed that EHBP1 promotes sortilin (SORT1)-mediated PCSK9 secretion, leading to LDLR degradation and less LDL uptake
ArdorComm Media News Network April 2, 2026 The Government of India has issued a comprehensive advisory on GLP-1 drugs, cautioning against their inappropriate use while acknowledging their growing role in managing type 2 diabetes and obesity
Energy The research is limited and far from a slam dunk but Cowling says higher doses of B 12 supplementation may increase energy, particularly if you have a deficiency or are at risk of a deficiency